Authors
Latest:
Data Suggest Combination Abilities of OP-1250, Palbociclib for Breast Cancer at SABCSOP-1250 and palbociclib showed “enhanced suppression of tumor growth” in preclinical mouse model studies, according to expert who presented his findings in a poster at the San Antonio Breast Cancer Symposium 2022.
Latest:
AACR Progress Report Highlights New Drugs Along With Disparities, Challenges of Obesity, Aging PopulationThe annual report notes that progress in reducing cancer mortality is uneven among populations, with minority groups not seeing the same benefits from therapeutic advances.
Latest:
Biologic Management for IBDWith increased specialty medication prescribing, associated costs, and the interest of health systems to establish specialty pharmacies for improved patient care, it is vital to define the pharmacist's role within the patient's health care team.
Latest:
PARP Inhibitors: A Novel Approach to Treating Ovarian CancerPARP inhibitors are novel therapies with indication focused on ovarian cancer; however, new agents are being studied for other cancers as well.
Latest:
My Burnout StoryI am grateful to those who identified my burnout and supported me to make changes and reverse the syndrome.
Latest:
MTM Spotlights Pharmacy's Patient Counseling RolePharmacists are in the perfect position to influence patients and improve outcomes with medication therapy management.
Latest:
Rehospitalizations and Direct Medical Costs for cSSSI: Linezolid Versus VancomycinAmong commercially insured patients treated with linezolid or vancomycin following cSSSI-related hospitalization, linezolid was associated with significantly lower rehospitalization rates and total direct medical costs.
Latest:
Takeda Pharmaceuticals America, Inc's EdarbiThe FDA approved Edarbi (azilsartan medoxomil), a new angiotensin receptor blocker, for the treatment of hypertension in adults.
Latest:
Which Left Ventricular Assist Device Is Best?Advanced heart failure leads to significant limitations, affecting functional status, quality of life, and survival, despite optimal medical treatment with evidence-based therapies.
Latest:
Changes Coming in Specialty Pharmacy AccreditationIf you're not accredited with any of the major players, you could instantly lose out on future business growth opportunities.
Latest:
Costs of Collagenase Clostridium Histolyticum and Fasciectomy for Dupuytren's ContractureA retrospective cohort analysis was conducted to compare disease-specific healthcare resource utilization and the costs of collagenase clostridium histolyticum and fasciectomy among adult Dupuytren’s contracture patients.
Latest:
Telephone-Based Cardiovascular Medication Therapy Management in Medicare Part D Enrollees With DiabetesA telephonic pharmacist-delivered medication therapy management intervention is an effective method for increasing the utilization of guideline-recommended cardiovascular therapies in high-risk Medicare patients with diabetes.
Latest:
Hepatitis CAchieving a sustained viral response in patients with hepatitis C is showed to reduce the risk of liver cancer.
Latest:
Infusion Pharmacist Expertise Vital in Helping Manage IG Shortages, Ensuring Right Drug Gets to the Right Patient at the Right DosePerceived as the new “wonder drug,” immunoglobulin (IG) is a go-to therapy for healthcare providers seeking to bolster their patients’ immune systems; however, as demand grows, particularly for oncology and off-label indications, the supply can’t keep pace.
Latest:
Prescribing Patterns of Novel Anticoagulants Within a Statewide Multispecialty PracticeWhile warfarin remains the most commonly prescribed anticoagulant, novel anticoagulant use appears to be increasing especially among cardiologists. With new indications for these agents, uptake in prescribing by primary care providers is likely to increase.
Latest:
Sustainable Health Care in Developing NationsSarah Scoular, PharmD, BCPS, assistant professor at the University of Colorado Skaggs School of Pharmacy, discusses some of the international work she has been involved in.
Latest:
Specialty Pharmacy: A Five-Pronged Approach to Managing CostSpecialty pharmacy is beginning to implement its own set of strategies in order to manage the cost of one of the most expensive sectors of the pharmaceutical industry.
Latest:
General Availability for .Pharmacy Domain Names Begins June 3, 2015The National Association of Boards of Pharmacy® (NABP®) is pleased to announce that general availability for the .pharmacy domain begins June 3, 2015.
Latest:
Persistence With Mirabegron Versus Tolterodine in Patients With Overactive BladderIn a retrospective analysis of the Optum database, overactive bladder patients treated with mirabegron bladder patients persisted longer with treatment than patients treated with tolterodine, and had reduced resource utilization and costs.
Latest:
Psoriasis Treatment Patterns: Phototherapy, Oral Nonbiologic, and Biologic TherapiesAmong psoriasis patients initiated on oral nonbiologic or on biologic therapy, most patients undergo at least 1 therapy change within 4 months of treatment initiation.
Latest:
Utility of Antithrombotic Therapy in Chronic Systolic Heart FailureThe primary care physician for a 67-year-old female patient with hypertension, dyslipidemia, and chronic non-ischemic systolic heart failure wants to know whether to initiate an antithrombotic agent.
Latest:
Supply Chain InnovationsComplex distribution challenges for manufacturers of specialty drugs require life science and cold chain experts to provide a faster, better way of distributing these life-saving medications.
Latest:
Impact of Co-Payment Discounts on Antidepressant Medication Adherence and CostsA unique co-payment discount program for antidepressants was associated with higher antidepressant medication adherence, lower likelihood of discontinuation, and lower healthcare costs.
Latest:
Self-Reported Plan Switching in Medicare Part D: 2006-2010Less than one-fourth of Part D beneficiaries reported switching plans. Elderly beneficiaries who reported switching did not realize significant savings in prescription costs over nonswitchers.
Latest:
Psoriasis Treatment Cost Comparison: Biologics Versus Home PhototherapyAn estimation and comparison of the cost of home phototherapy versus biologics over a 3-year time horizon in patients with moderate-to-severe plaque psoriasis.
